相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea
Elhadj Ibrahima Bah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses
Roosecelis Brasil Martines et al.
JOURNAL OF PATHOLOGY (2015)
Successful Delivery of RRT in Ebola Virus Disease
Michael J. Connor et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Safety and Pharmacokinetic Profiles of Phosphorodiamidate Morpholino Oligomers with Activity against Ebola Virus and Marburg Virus: Results of Two Single-Ascending-Dose Studies
Alison E. Heald et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
Lisa Oestereich et al.
ANTIVIRAL RESEARCH (2014)
Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
Sophie J. Smither et al.
ANTIVIRAL RESEARCH (2014)
Ebolavirus in West Africa, and the use of experimental therapies or vaccines
Thomas Hoenen et al.
BMC BIOLOGY (2014)
Possible leap ahead in filovirus therapeutics
Darryl Falzarano et al.
CELL RESEARCH (2014)
Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses
Diana F. Florescu et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Reverse genetics systems as tools for the development of novel therapies against filoviruses
Thomas Hoenen et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Travis K. Warren et al.
NATURE (2014)
Case fatality rates of Ebola virus diseases: A meta-analysis of World Health Organization data
A. Lefebvre et al.
MEDECINE ET MALADIES INFECTIEUSES (2014)
Emergence of Zaire Ebola Virus Disease in Guinea
Sylvain Baize et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Studying Secret Serums - Toward Safe, Effective Ebola Treatments
Jesse L. Goodman
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
J. S. Schieffelin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia
Benno Kreuels et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
What Obstetrician-Gynecologists Should Know About Ebola A Perspective From the Centers for Disease Control and Prevention
Denise J. Jamieson et al.
OBSTETRICS AND GYNECOLOGY (2014)
Basic Science and the Ebola Virus Infection Epidemic
C. Lindsay DeVane
PHARMACOTHERAPY (2014)
Structures of protective antibodies reveal sites of vulnerability on Ebola virus
Charles D. Murin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Fighting Ebola with ZMapp: spotlight on plant-made antibody
Zhang YunFang et al.
SCIENCE CHINA-LIFE SCIENCES (2014)
Post-exposure therapy of filovirus infections
Gary Wong et al.
TRENDS IN MICROBIOLOGY (2014)
Favipiravir elicits antiviral mutagenesis during virus replication in vivo
Armando Arias et al.
ELIFE (2014)
Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease
Anita K. McElroy et al.
EMERGING INFECTIOUS DISEASES (2014)
Emerging Targets and Novel Approaches to Ebola Virus Prophylaxis and Treatment
Jin Huk Choi et al.
BIODRUGS (2013)
Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
James Pettitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Pathogenesis of the Viral Hemorrhagic Fevers
Slobodan Paessler et al.
Annual Review of Pathology-Mechanisms of Disease (2012)
Characterization of the RNA Silencing Suppression Activity of the Ebola Virus VP35 Protein in Plants and Mammalian Cells
Yali Zhu et al.
JOURNAL OF VIROLOGY (2012)
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
Gene Garrard Olinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections
Patrick L. Iversen et al.
VIRUSES-BASEL (2012)
The ebolavirus VP24 interferon antagonist Know your enemy
Adrianna P. P. Zhang et al.
VIRULENCE (2012)
The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
Adrianna P. P. Zhang et al.
PLOS PATHOGENS (2012)
Role of VP30 Phosphorylation in the Ebola Virus Replication Cycle
Miguel J. Martinez et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Ebolavirus Proteins Suppress the Effects of Small Interfering RNA by Direct Interaction with the Mammalian RNA Interference Pathway
Giulia Fabozzi et al.
JOURNAL OF VIROLOGY (2011)
Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses
Joseph E. Blaney et al.
JOURNAL OF VIROLOGY (2011)
Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology
Douglas S. Reed et al.
MICROBES AND INFECTION (2011)
Microbial Induction of Vascular Pathology in the CNS
Silvia S. Kang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
Thomas W. Geisbert et al.
LANCET (2010)
Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions
Daniel G. Bausch et al.
ANTIVIRAL RESEARCH (2008)
Treatment of Argentine hemorrhagic fever
Delia A. Enria et al.
ANTIVIRAL RESEARCH (2008)
Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit
Mark G. Kortepeter et al.
EMERGING INFECTIOUS DISEASES (2008)
Ebola hemorrhagic fever: Evaluation of passive immunotherapy in nonhuman primates
Peter B. Jahrling et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Immunopathology of highly virulent pathogens: insights from Ebola virus
Carisa A. Zampieri et al.
NATURE IMMUNOLOGY (2007)
The Ebola virus VP35 protein is a suppressor of RNA silencing
Joost Haasnoot et al.
PLOS PATHOGENS (2007)
Progress towards the treatment of Ebola haemorrhagic fever
Ute Stroher et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference
Thomas W. Geisbert et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice
S Enterlein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers
Kelly L. Warfield et al.
PLOS PATHOGENS (2006)
Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function
VM Wahl-Jensen et al.
JOURNAL OF VIROLOGY (2005)
Pathogenesis of filoviral haemorrhagic fevers
S Mahanty et al.
LANCET INFECTIOUS DISEASES (2004)
Production of novel Ebola virus-like particles from cDNAs: an alternative to Ebola virus generation by reverse genetics
S Watanabe et al.
JOURNAL OF VIROLOGY (2004)
Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: Cellular responses, virus load, and nitric oxide levels
A Sanchez et al.
JOURNAL OF VIROLOGY (2004)
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques - Evidence that dendritic cells are early and sustained targets of infection
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3
CF Basler et al.
JOURNAL OF VIROLOGY (2003)
Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice
TR Gibb et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2001)
Early immune responses accompanying human asymptomatic Ebola infections
EM Leroy et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
分享论文
